Exact Sciences
EXAS
#1765
Rank
A$14.44 B
Marketcap
$78.05
Share price
-3.29%
Change (1 day)
-16.92%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -A$0.24 Billion

According to Exact Sciences's latest financial reports the company's current earnings are A$2.61 Billion. In 2023 the company made an earning of -A$0.29 Billion, an increase over its 2022 earnings that were of -A$0.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.24 Billion-16.83%
2023 -A$0.29 Billion-69.98%
2022 -A$0.94 Billion-25.55%
2021 -A$1.26 Billion1.68%
2020 -A$1.24 Billion271.17%
2019 -A$0.34 Billion58.99%
2018 -A$0.21 Billion20.89%
2017 -A$0.18 Billion-30.95%
2016 -A$0.26 Billion5.09%
2015 -A$0.24 Billion57.24%
2014 -A$0.16 Billion116.53%
2013 -A$70.2 Million
2011 -A$43.71 Million143.73%
2010 -A$17.94 Million27.85%
2009 -A$14.03 Million0.27%
2008 -A$13.99 Million-20.95%
2007 -A$17.7 Million-13.53%
2006 -A$20.47 Million-10.07%
2005 -A$22.76 Million-21.81%
2004 -A$29.11 Million-33.44%
2003 -A$43.73 Million-6.51%
2002 -A$46.77 Million17.95%
2001 -A$39.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$99.88 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$83.07 Million-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$53.02 Million-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.23 B-4,883.42%๐Ÿ‡ซ๐Ÿ‡ท France